Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]

Astrid K. Gnekow; David A. Walker; Daniela Kandels; Susan Picton; Giorgio Perilongo; Jacques Grill; Tore Stokland; Per Eric Sandstrsom; Monica Warmuth-Metz; Torsten Pietsch; Felice Giangaspero; René Schmidt; Andreas Faldum; Denise Kilmartin; Angela De Paoli; Gian Luca De Salvo; Jordi Giralt Lopez de Sagredo

doi:10.1016/j.ejca.2017.11.017

Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]

Astrid K. Gnekow, David A. Walker^*, Daniela Kandels, Susan Picton, Giorgio Perilongo, Jacques Grill, Tore Stokland, Per Eric Sandstrsom, Monica Warmuth-Metz, Torsten Pietsch, Felice Giangaspero, René Schmidt, Andreas Faldum, Denise Kilmartin, Angela De Paoli, Gian Luca De Salvo, Jordi Giralt Lopez de Sagredo

^*Autor corresponent d’aquest treball

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca

3 Cites (Scopus)

Idioma original	Anglès
Pàgines (de-a)	156-157
Nombre de pàgines	2
Revista	European Journal of cancer
Volum	90
Número	1
DOIs	https://doi.org/10.1016/j.ejca.2017.11.017
Estat de la publicació	Publicada - de febr. 2018

Accés al document

10.1016/j.ejca.2017.11.017Llicència: Creative Commons Reconeixement

Altres arxius i enllaços

Com citar-ho

Gnekow, A. K., Walker, D. A., Kandels, D., Picton, S., Perilongo, G., Grill, J., Stokland, T., Sandstrsom, P. E., Warmuth-Metz, M., Pietsch, T., Giangaspero, F., Schmidt, R., Faldum, A., Kilmartin, D., De Paoli, A., De Salvo, G. L., & Giralt Lopez de Sagredo, J. (2018). Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]. European Journal of cancer, 90(1), 156-157. https://doi.org/10.1016/j.ejca.2017.11.017

Gnekow, Astrid K. ; Walker, David A. ; Kandels, Daniela et al. / Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]. In: European Journal of cancer. 2018 ; Vol. 90, Núm. 1. pàg. 156-157.

@article{6474bed280c948e5a5118cba1867101e,

title = "Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]",

author = "Gnekow, \{Astrid K.\} and Walker, \{David A.\} and Daniela Kandels and Susan Picton and Giorgio Perilongo and Jacques Grill and Tore Stokland and Sandstrsom, \{Per Eric\} and Monica Warmuth-Metz and Torsten Pietsch and Felice Giangaspero and Ren{\'e} Schmidt and Andreas Faldum and Denise Kilmartin and \{De Paoli\}, Angela and \{De Salvo\}, \{Gian Luca\} and \{Giralt Lopez de Sagredo\}, Jordi",

year = "2018",

month = feb,

doi = "10.1016/j.ejca.2017.11.017",

language = "English",

volume = "90",

pages = "156--157",

journal = "European Journal of cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "1",

}

Gnekow, AK, Walker, DA, Kandels, D, Picton, S, Perilongo, G, Grill, J, Stokland, T, Sandstrsom, PE, Warmuth-Metz, M, Pietsch, T, Giangaspero, F, Schmidt, R, Faldum, A, Kilmartin, D, De Paoli, A, De Salvo, GL & Giralt Lopez de Sagredo, J 2018, 'Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]', European Journal of cancer, vol. 90, núm. 1, pàg. 156-157. https://doi.org/10.1016/j.ejca.2017.11.017

Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]. / Gnekow, Astrid K.; Walker, David A.; Kandels, Daniela et al.
In: European Journal of cancer, Vol. 90, Núm. 1, 02.2018, pàg. 156-157.

Producció científica: Contribució a revista › Article › Recerca

TY - JOUR

T1 - Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]

AU - Gnekow, Astrid K.

AU - Walker, David A.

AU - Kandels, Daniela

AU - Picton, Susan

AU - Perilongo, Giorgio

AU - Grill, Jacques

AU - Stokland, Tore

AU - Sandstrsom, Per Eric

AU - Warmuth-Metz, Monica

AU - Pietsch, Torsten

AU - Giangaspero, Felice

AU - Schmidt, René

AU - Faldum, Andreas

AU - Kilmartin, Denise

AU - De Paoli, Angela

AU - De Salvo, Gian Luca

AU - Giralt Lopez de Sagredo, Jordi

PY - 2018/2

Y1 - 2018/2

UR - http://dx.doi.org/10.1016/j.ejca.2017.11.017

UR - https://www.scopus.com/pages/publications/85039860375

U2 - 10.1016/j.ejca.2017.11.017

DO - 10.1016/j.ejca.2017.11.017

M3 - Article

SN - 0959-8049

VL - 90

SP - 156

EP - 157

JO - European Journal of cancer

JF - European Journal of cancer

IS - 1

ER -

Gnekow AK, Walker DA, Kandels D, Picton S, Perilongo G, Grill J et al. Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]. European Journal of cancer. 2018 febr.;90(1):156-157. doi: 10.1016/j.ejca.2017.11.017